September 8, 2023

deepc announces partnership with Qubiotech

We are pleased to announce the latest addition to deepcOS- Qubiotech's NeuroCloud PET and Neurocloud VOL

deepc announces the latest addition to deepcOS- Qubiotech's NeuroCloud PET and Neurocloud VOL.

Neurocloud PET is the software for the quantitative analysis of brain PET FDG and Amyloid studies, which provides professionals in neurology and nuclear medicine with automatic assistance in the diagnosis and monitoring of neurodegenerative diseases.

Neurocloud VOL graphically identifies atrophy in the patient’s brain, segments and identifies inflammatory lesions, and assists in the follow-up and evolution of the pathology, such as growth/decrease of lesions or appearance of new lesions, providing a longitudinal analysis of the imaging studies.
"I have been using Neurocloud for years as a quantification assistant for 18FDG PET neurology studies. In our experience, in 1 out of 3 cases the use of Neurocloud improved the diagnosis and the confidence of the reporting physician, and confirmed the visual findings in the remaining cases." - Dr. Carlos Torrijo, CASA DE SALUD HOSPITAL (Valencia, Spain)

Together with our partners, we are pioneering the future of AI Solutions, revolutionizing the Radiology industry.

Outstanding together in radiology AI!

About deepc

deepc has developed the radiology AI platform deepcOS, providing clinicians with easy access to an ecosystem of regulatory-approved, globally leading AI solutions for more than 50 clinical indications. deepc offers easy installation, with one contract, billing, service, and support framework in compliance with all data protection and cybersecurity requirements.